The speed of many of our clients to join the battle in fighting the development and spread of COVID-19 has made us immensely proud. This has come from some focusing their innovative skills on new problem, or by others pivoting already developed technology to focus on COVID-19.  This is not restricted to innovators in the life sciences or pharmaceutical sciences, but also engineering solutions, innovations relating to PPE and IT solutions. The need to redouble and focus our collective innovative efforts has been recognised by many funding bodies. 

Updated 15th April 2020

If you are taking up this challenge and looking for some additional funding, you may be able to find assistance from one of the following:-

Innovate UK

The aim of this competition is to support UK businesses to focus on emerging or increasing needs of society and industries during and following the Covid-19 pandemic.

Deadline = 17 April 2020

Defence and Security Accelerator (DASA)

Deadlines = 15 April and 28 April 2020

DASA is currently seeking any idea or novel approach that could boost the Ministry of Defence’s capabilities in support of the national effort against Coronavirus (Covid-19).

European Commission

The Executive Agency for Small and Medium-sized Enterprises, under the LIFE programme, invites applications for its integrated projects call. This supports the implementation of large territorial scale environmental and climate plans or strategies within the EU. Integrated projects should aim towards the full implementation of the targeted plan or strategy. All applicants are encouraged to look at their project idea and identify any element that could potentially improve the collective ability to avoid a crisis similar to COVID-19 outbreak in the future. Projects can financially support small, local initiatives. UK-based legal persons are eligible to participate under this call.

Deadline = 6 October 2020


In response to the unprecedented COVID-19 pandemic, Diabetes UK are making £100,000 available for scientists to study how coronavirus affects people living with diabetes.

Deadline = 20th April 2020

European Spallation Source

The Deuteration & Macromolecular Crystallisation (DEMAX) platform at ESS is offering prioritised access to laboratory services for scientists and researchers working on COVID-19-related research projects.


Call for Code asks innovators to create practical, effective, and high-quality applications based on one or more IBM Cloud™ services (for example, web, mobile, data, analytics, AI, IoT, or weather) that can have an immediate and lasting impact on humanitarian issues. Teams of developers, data scientists, designers, business analysts, subject matter experts and more are challenged to build solutions to mitigate the impact of COVID-19 and climate change.


NHLBI is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.

Deadline = 6 October 2020

National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes, i.e., “coronavirus disease 2019” (COVID-19). NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial.

Deadline = 17 October 2020

A better understanding of the host response, associated disease, and short- and long-term clinical outcomes of individuals infected with SARS-CoV-2. For NHGRI grantees only (including those with a current extension of funds or a no cost extension), we encourage the submission of applications for Competitive Revisions to support genomic research on SARS-CoV-2 and COVID-19 disease. Of particular interest are genomic studies utilizing generalized approaches that take advantage of human research or model systems to study the consequences of SARS-CoV-2 infection. Supported research is expected to guide and inform future efforts to diagnose, prevent, mitigate, or treat this viral infection.

Deadline = 16 May 2020

NIA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19). The mission of NIA is to support and conduct genetic, biological, clinical, behavioral, social, and economic research on aging. This NOSI supports mission critical areas of research for NIA as they relate to the COVID-19 pandemic.

Deadline = 1 May 2020

COVID-19 HPC Consorium

The COVID-19 HPC Consortium encompasses computing capabilities from some of the most powerful and advanced computers in the world. We hope to empower researchers around the world to accelerate understanding of the COVID-19 virus and the development of treatments and vaccines to help address infections. Consortium members manage a range of computing capabilities that span from small clusters to some of the very largest supercomputers in the world.


As part of the COVID-19 Solutions Fund, Moz://a will accept applications that are hardware (e.g., an open source ventilator), software (e.g., a platform that connects hospitals with people who have 3D printers who can print parts for that open source ventilator), as well as software that solves for secondary effects of COVID-19 (e.g., a browser plugin that combats COVID related misinformation).

Open Road Alliance

For organizations engaging in direct COVID-19 response. We will prioritize organizations and activities that have a clear and direct role in ‘flattening the curve’ and thus limiting, shortening, or minimizing the economic and social, as well as health effects of the pandemic.


The UKRI are putting together processes to allow researchers to repurpose existing UKRI standard grant to address COVID-19 research priorities.


The European and Developing Countries Clinical Trials Partnership, through its Emergency funding mechanism, invites applications for its mobilisation of funding for COVID-19 research in sub-Saharan Africa. This supports research and innovation actions activities in sub-Saharan Africa on managing or preventing the spread of the current COVID-19 outbreak.

Deadline =  17 April 2020.


European Space Agency, together with the Italian Minister for Technological Innovation and Digitalisation, invites tenders for its space in response to COVID-19 outbreak call. The tenderer will deploy and demonstrate services to respond to the emergency that Europe, and especially Italy, is facing because of the spread of the coronavirus.

Deadline = 20 April 2020.

Welcome Trust

Currently closed, but under review so watch this space.


All latest updates